Risk Factors for Severity of Adverse Events Associated with Xuebijing Injection: A Propensity Score-Matched Analysis

ZHENG Rui; CHEN Zhuo; ZHONG Xiao-ying; CHEN Zhao; WANG Peng-qian; CUI He-rong; SHANG Hong-cai

doi:10.1007/s11655-025-4024-5

Your Location：

Home >

Browse articles >

Risk Factors for Severity of Adverse Events Associated with Xuebijing Injection: A Propensity Score-Matched Analysis

Herb-Drug Interaction | Updated：2026-08-04

- Risk Factors for Severity of Adverse Events Associated with Xuebijing Injection: A Propensity Score-Matched Analysis
- Risk Factors for Severity of Adverse Events Associated with Xuebijing Injection: A Propensity Score-Matched Analysis
- 中国结合医学杂志（英文版） 2026年32卷第6期页码：553-559
- Affiliations：
  
  1.Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing (100700), China
  2.Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing (100700), China
  3.Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing (100700), China
  4.School of Life Sciences, Beijing University of Chinese Medicine, Beijing (102488), China
  5.Dongfang Hospital, Beijing University of Chinese Medicine, Beijing (100078), China
- Author bio：
  
  Prof. SHANG Hong-cai, E-mail: shanghongcai@126.com
- Funds：
  
  the National Natural Science Foundation of China(82204937);the Central High-Level Traditional Chinese Medicine Hospital Clinical Research Funding(DZMG-QNGG0008);the Chinese Medicine Inheritance and Innovation "Thousand Million" Talents Project (Qihuang Project) Qihuang Scholars(RS086);the Beijing University of Chinese Medicine Qi Huang Talent Program for Outstanding Young Scientists(K2023C12)
- DOI：10.1007/s11655-025-4024-5
  中图分类号：
- 录用：2025-07-22，
  
  网络首发：2025-11-18，
  
  纸质出版：2026-06
- Accepted：
Scan QR Code
ZHENG Rui, CHEN Zhuo, ZHONG Xiao-ying, 等. Risk Factors for Severity of Adverse Events Associated with Xuebijing Injection: A Propensity Score-Matched Analysis[J]. 中国结合医学杂志（英文版）, 2026,32(6):553-559.

ZHENG Rui, CHEN Zhuo, ZHONG Xiao-ying, et al. Risk Factors for Severity of Adverse Events Associated with Xuebijing Injection: A Propensity Score-Matched Analysis[J]. Chinese Journal of Integrative Medicine, 2026, 32(6): 553-559.
ZHENG Rui, CHEN Zhuo, ZHONG Xiao-ying, 等. Risk Factors for Severity of Adverse Events Associated with Xuebijing Injection: A Propensity Score-Matched Analysis[J]. 中国结合医学杂志（英文版）, 2026,32(6):553-559. DOI： 10.1007/s11655-025-4024-5.

ZHENG Rui, CHEN Zhuo, ZHONG Xiao-ying, et al. Risk Factors for Severity of Adverse Events Associated with Xuebijing Injection: A Propensity Score-Matched Analysis[J]. Chinese Journal of Integrative Medicine, 2026, 32(6): 553-559. DOI： 10.1007/s11655-025-4024-5.

摘要

Abstract

Objective:

To determine risk factors associated with the severity of Xuebijing Injection (XBJ)-related adverse events (AEs).

Methods:

Totally 16

031 cases reported XBJ-related AEs were retrospectively analyzed from China national spontaneous reporting system (SRS) from its inception to 2022. Factors including age

gender

weight

ethnicity

family history

and allergic history were examined. Univariate and multivariate logistic regression analyses were performed

followed by propensity score matching (PSM) to control for confounding factors.

Results:

A total of 11

131 XBJ-related AE cases were identified after excluding duplicates and incomplete reports

including 9

771 general and 1

360 serious AEs. Serious AEs were mainly distributed among respiratory

thoracic and mediastinal disorders (27.00%). Univariate analysis identified gender

age

history of allergies

and previous AE history

XBJ-other β-lactam antimicrobials combination and XBJ-aminoglycoside antimicrobials combination were potential risk factors of serious AEs (

0.05 or

0.01). Multivariate analysis identified age

gender

history of allergies

and XBJ-other β-lactam antimicrobials combination as significant risk factors of AE severity (

0.05 or

0.01). PSM further confirmed that patients receiving XBJ combined with β-lactam antibiotics had a significantly higher risk of severe AEs (odds ratio=1.913

=0.019).

Conclusions:

The risk factors influencing the severity of XBJ include age

gender

history of allergies

and its combination with other β-lactam antimicrobials. Among them

PSM further proved that the XBJ-other β-lactam antimicrobials combination needs to be given attention in clinical practice.

关键词

Keywords

references

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Effect and Safety of Xinfuli Granules in Chronic Heart Failure with Qi Deficiency and Blood Stasis: A Single-Center Randomized Controlled Trial

Efficacy and Safety of Aurantii Fructus Immaturus Flavonoid Tablets in Patients with Functional Dyspepsia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Clinical Trial

Efficacy and Safety of Jianpi Jieyu Decoction for Patients with Mild-to-Moderate Depression of Xin (Heart)-Pi (Spleen) Deficiency Syndrome: A Multi-centre Randomized Controlled Study

Efficacy and Safety of Mulberry Twig Alkaloids Tablet for Treatment of Type 2 Diabetes: A Randomized, Double-Blind,Placebo-Controlled Multicenter Clinical Study

Xuebijing Injection Ameliorates H2S-Induced Acute Respiratory Distress Syndrome by Promoting Claudin-5 Expression